Publisher: John Wiley & Sons Inc
E-ISSN: 1463-1326|18|S1|97-101
ISSN: 1462-8902
Source: DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol.18, Iss.S1, 2016-09, pp. : 97-101
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Recent studies in animal models and human pathological specimens suggest the involvement of β‐cell dedifferentiation in β‐cell dysfunction associated with type 2 diabetes. Dedifferentiated β‐cells may be exploited for endogenous renewal of the β‐cell mass. However, studying human β‐cell dedifferentiation in diabetes presents major difficulties. We have analysed mechanisms involved in human β‐cell dedifferentiation in vitro, under conditions that allow cell proliferation. Although there are important differences between the two cellular environments, β‐cell dedifferentiation in the two conditions is likely to share a number of common pathways. Insights from the in vitro studies may lead to development of approaches for redifferentiation of endogenous dedifferentiated β‐cells.
Related content
Mechanisms of β‐cell functional adaptation to changes in workload
DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. S1, 2016-09 ,pp. :
Novel factors modulating human β‐cell proliferation
DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. S1, 2016-09 ,pp. :
β‐Cell adaptation in pregnancy
DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. S1, 2016-09 ,pp. :
Pancreatic β‐cell identity in diabetes
DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 18, Iss. S1, 2016-09 ,pp. :